- List
- By Topic
- On Map
- Search Details

cataract AND Ophthalmic
Need help? See RSS Feeds
Choose a feed type:

cataract AND Ophthalmic (1212 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02973880 | Completed | Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
180 | All | 40 Years and older (Adult, Older Adult) | NCT02973880 | 044-SI 2016-002138-63 |
October 15, 2017 | December 1, 2018 | December 30, 2018 | November 25, 2016 | January 14, 2019 |
|
|||
2 | NCT01367249 | Completed Has Results |
Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
440 | All | 18 Years and older (Adult, Older Adult) | NCT01367249 | S00124 | May 2011 | July 2011 | December 2011 | June 7, 2011 | May 6, 2014 | May 6, 2014 |
|
||
3 | NCT03640351 | Recruiting | Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
150 | All | 20 Years and older (Adult, Older Adult) | NCT03640351 | 4-2017-0601 | August 15, 2017 | August 14, 2019 | August 14, 2019 | August 21, 2018 | February 8, 2019 |
|
|||
4 | NCT03125785 | Not yet recruiting | The Effect of Ophthalmic Solutions on Contact Lenses Used After Surgery for Congenital Cataract Investigated in Vivo |
|
Observational |
|
Other |
|
|
80 | All | up to 7 Years (Child) | NCT03125785 | saradelima1 | June 2017 | December 2018 | December 2019 | April 24, 2017 | May 24, 2017 | ||||||
5 | NCT02128113 | Completed | RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
304 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02128113 | RTA 408-C-1309 | May 2014 | February 2015 | April 2015 | May 1, 2014 | February 26, 2016 |
|
|||
6 | NCT02734459 | Completed | A Bioequivalence Study to Compare the Pharmacokinetics (PK) Of Marketed Product TobraDex® To An Experimental Ophthalmic Sterile Ointment Containing Tobramycin And Dexamethasone In Aqueous Humor In Patients Undergoing Indicated Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
756 | All | 18 Years and older (Adult, Older Adult) | NCT02734459 | S-10-084 | TBO | November 2013 | October 2015 | March 2016 | April 12, 2016 | April 12, 2016 | |||
7 | NCT03020056 | Active, not recruiting | Impact of Cataract Surgery to Socioeconomic Status in Rural Area |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
278 | All | 50 Years and older (Adult, Older Adult) | NCT03020056 | 2016KYYJ007 | ICSSES | January 16, 2017 | December 2018 | February 2019 | January 13, 2017 | October 3, 2018 |
|
||
8 | NCT01344226 | Completed Has Results |
Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery |
|
|
Observational |
|
Other |
|
|
49 | All | 18 Years and older (Adult, Older Adult) | NCT01344226 | MMC-2011A | April 2011 | September 2013 | September 2013 | April 29, 2011 | October 22, 2018 | October 22, 2018 |
|
|||
9 | NCT01016405 | Completed | Prospective Health Assessment of Cataract Patients' Ocular Surface |
|
Observational |
|
Industry |
|
|
200 | All | 55 Years and older (Adult, Older Adult) | NCT01016405 | 0167 | June 2009 | September 2010 | September 2010 | November 19, 2009 | February 1, 2011 |
|
|||||
10 | NCT02571556 | Completed | OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL) |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
80 | All | 18 Years to 85 Years (Adult, Older Adult) | NCT02571556 | EGP-437-008 | November 2015 | October 2016 | November 2016 | October 8, 2015 | November 30, 2016 |
|
|||
11 | NCT01426854 | Completed Has Results |
Nepafenac Compared to Placebo for Ocular Pain and Inflammation |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
260 | All | 18 Years and older (Adult, Older Adult) | NCT01426854 | C-10-026 | July 2011 | April 2012 | April 2012 | September 1, 2011 | May 13, 2013 | May 13, 2013 |
|
||
12 | NCT00575380 | Completed Has Results |
Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
116 | All | 21 Years and older (Adult, Older Adult) | NCT00575380 | 041-103 P08655 |
December 2007 | June 2008 | December 18, 2007 | September 22, 2011 | September 16, 2009 |
|
|||
13 | NCT01847638 | Completed Has Results |
Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
50 | All | 18 Years and older (Adult, Older Adult) | NCT01847638 | MMT-2013 | QD | April 1, 2013 | July 16, 2016 | August 23, 2018 | May 7, 2013 | November 14, 2018 | November 14, 2018 |
|
|
14 | NCT00198445 | Completed | Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
527 | All | 18 Years and older (Adult, Older Adult) | NCT00198445 | ISTA-BR-CS001 | May 2003 | January 2004 | January 2004 | September 20, 2005 | March 14, 2013 |
|
|||
15 | NCT00333918 | Completed | Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
522 | All | 18 Years and older (Adult, Older Adult) | NCT00333918 | ISTA-BR-CS02 | June 2006 | March 2007 | March 2007 | June 6, 2006 | February 15, 2013 |
|
|||
16 | NCT00703781 | Completed Has Results |
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
126 | All | 18 Years and older (Adult, Older Adult) | NCT00703781 | CL-S&E-0415081-P-ER | June 2008 | November 2008 | June 24, 2008 | March 24, 2015 | December 9, 2011 |
|
|||
17 | NCT01230125 | Completed | Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
250 | All | 18 Years and older (Adult, Older Adult) | NCT01230125 | 663 | November 2010 | June 2011 | August 2011 | October 28, 2010 | December 17, 2013 |
|
|||
18 | NCT00924729 | Completed Has Results |
Study of Ocular Penetration of Topically Administered Fluoroquinolones |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
50 | All | 21 Years and older (Adult, Older Adult) | NCT00924729 | NA_28692 | September 2009 | October 2009 | November 2009 | June 19, 2009 | October 24, 2017 | March 11, 2010 |
|
||
19 | NCT03749759 | Recruiting | Perioperative Stress and Pain Perception of Second Eye Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
39 | All | 21 Years to 105 Years (Adult, Older Adult) | NCT03749759 | Neuromaster | January 1, 2017 | January 1, 2019 | January 1, 2019 | November 21, 2018 | November 21, 2018 |
|
|||
20 | NCT02573610 | Completed | Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
576 | All | 19 Years and older (Adult, Older Adult) | NCT02573610 | DE-108 | September 21, 2015 | March 31, 2017 | March 31, 2017 | October 12, 2015 | October 12, 2017 |
|
|||
21 | NCT03317847 | Active, not recruiting | Bromfenac Versus Dexamethasone After Cataract Surgery |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
76 | All | 60 Years to 90 Years (Adult, Older Adult) | NCT03317847 | Eudract 2016-004358-14 | BVD | October 16, 2017 | June 14, 2018 | December 2018 | October 23, 2017 | June 18, 2018 |
|
||
22 | NCT02124603 | Completed Has Results |
Microbiological Evaluation of the Ocular Flora Before Cataract Surgery |
|
Observational |
|
Industry |
|
|
120 | All | 18 Years and older (Adult, Older Adult) | NCT02124603 | 041SI | April 2014 | October 2014 | October 2014 | April 28, 2014 | January 18, 2016 | September 29, 2015 |
|
||||
23 | NCT00793091 | Unknown † | Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
80 | All | 50 Years to 85 Years (Adult, Older Adult) | NCT00793091 | CK-0109 | November 2008 | August 2009 | September 2009 | November 19, 2008 | November 27, 2008 |
|
|||
24 | NCT01824927 | Unknown † | Pain Expression in the Perioperative Period of Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
150 | All | 50 Years to 85 Years (Adult, Older Adult) | NCT01824927 | EBCS001 NSFC81200669 |
January 2013 | May 2013 | April 5, 2013 | April 5, 2013 |
|
||||
25 | NCT02423668 | Completed | Pseudophakic Anterior Chamber Depth Measurement in Second Eye Refinement Cataract Surgery |
|
|
Observational |
|
Other |
|
|
88 | All | 18 Years and older (Adult, Older Adult) | NCT02423668 | CHBaixoVouga3 | January 2015 | March 2015 | March 2015 | April 22, 2015 | April 22, 2015 | |||||
26 | NCT00870103 | Completed Has Results |
Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
64 | All | 18 Years and older (Adult, Older Adult) | NCT00870103 | RM-08-05 | September 2008 | February 2009 | March 26, 2009 | March 9, 2010 | February 15, 2010 |
|
|||
27 | NCT01441895 | Unknown † | Corneal Sensation and Incidence of Dry Eye Post Refractive Cataract Extraction With FemtoSecond Laser |
|
Observational |
|
Other / Industry |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT01441895 | AGN02-FEMTO | September 2011 | December 2016 | December 2016 | September 28, 2011 | April 25, 2016 |
|
|||||
28 | NCT01244334 | Completed | Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
52 | All | 21 Years and older (Adult, Older Adult) | NCT01244334 | SEMC 5/2009-011 | March 2009 | June 2010 | November 2010 | November 19, 2010 | August 8, 2012 |
|
|||
29 | NCT01602068 | Completed Has Results |
Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Delivery Prior to Implantation of a Posterior Chamber IOL |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
45 | All | 18 Years and older (Adult, Older Adult) | NCT01602068 | EGP-437-005 | May 2012 | October 2012 | October 2012 | May 18, 2012 | January 29, 2019 | May 21, 2018 |
|
||
30 | NCT00699153 | Completed Has Results |
Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
400 | All | 18 Years and older (Adult, Older Adult) | NCT00699153 | 526 | June 2008 | May 2009 | June 2009 | June 17, 2008 | March 24, 2015 | September 23, 2010 |
|
||
31 | NCT00425464 | Terminated | A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Synchrony Dual Optic Intraocular Lens in Patients Undergoing Cataract Extraction |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
410 | All | 50 Years and older (Adult, Older Adult) | NCT00425464 | SYNC-601-IOL | November 2005 | April 2013 | April 2013 | January 23, 2007 | September 19, 2013 |
|
|||
32 | NCT01298752 | Terminated | Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
142 | All | 18 Years and older (Adult, Older Adult) | NCT01298752 | 664 | February 2011 | September 2011 | November 2011 | February 18, 2011 | December 17, 2013 |
|
|||
33 | NCT01471561 | Completed | Analysis of Cataract Surgery Induced Dry Eye |
|
Observational |
|
Industry |
|
|
61 | All | 18 Years and older (Adult, Older Adult) | NCT01471561 | TP00099 | October 2011 | September 2012 | September 2012 | November 16, 2011 | February 4, 2016 |
|
|||||
34 | NCT01515826 | Withdrawn | VIGADEXA Gel Compared to VIGADEXA Solution Following Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
0 | All | 18 Years and older (Adult, Older Adult) | NCT01515826 | C-10-013 | March 2014 | October 2014 | October 2014 | January 24, 2012 | March 26, 2014 | ||||
35 | NCT02681679 | Completed | Topical 0.1% Bromfenac Sodium and Prostaglandin E2 Inhibition in Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
60 | All | 50 Years and older (Adult, Older Adult) | NCT02681679 | CCPMOH2016-China-1 | October 2014 | December 2015 | December 2015 | February 12, 2016 | February 12, 2016 |
|
|||
36 | NCT00704418 | Completed Has Results |
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
156 | All | 18 Years and older (Adult, Older Adult) | NCT00704418 | CL-S&E-0415081-P-WR | June 2008 | January 2009 | December 2009 | June 24, 2008 | January 18, 2013 | January 26, 2011 |
|
||
37 | NCT00825721 | Unknown † | Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
81 | All | 35 Years to 90 Years (Adult, Older Adult) | NCT00825721 | CK-0105 | November 2007 | August 2009 | September 2009 | January 21, 2009 | January 21, 2009 |
|
|||
38 | NCT03458442 | Active, not recruiting | China OLIMPICS: China Ophthalmic Learning and Improvement Initiative in Cataract Surgery Trial |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
32 | All | up to 100 Years (Child, Adult, Older Adult) | NCT03458442 | China OLIMPICS* Trial | May 9, 2018 | January 2019 | February 2019 | March 8, 2018 | December 11, 2018 |
|
|||
39 | NCT00645671 | Completed Has Results |
Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
400 | All | 18 Years and older (Adult, Older Adult) | NCT00645671 | 525 | March 2008 | March 2009 | March 2009 | March 28, 2008 | March 24, 2015 | September 23, 2010 |
|
||
40 | NCT01591161 | Completed | Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
369 | All | 18 Years and older (Adult, Older Adult) | NCT01591161 | 790 | July 2012 | June 2013 | July 2013 | May 3, 2012 | December 17, 2013 |
|
|||
41 | NCT03035864 | Completed | A 8 Weeks Study to Evaluate Efficacy & Safety of rhNGF vs Vehicle in Patients After Cataract and Refractive Surgery |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
180 | All | 18 Years and older (Adult, Older Adult) | NCT03035864 | NGF0116 | January 12, 2017 | September 4, 2017 | September 4, 2017 | January 30, 2017 | July 24, 2018 |
|
|||
42 | NCT02028754 | Completed Has Results |
A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
180 | All | 60 Years to 80 Years (Adult, Older Adult) | NCT02028754 | CN-CMC-1101 | RLOTUS | July 2011 | May 2013 | May 2013 | January 7, 2014 | April 23, 2014 | April 23, 2014 |
|
|
43 | NCT01591655 | Completed | Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
363 | All | 18 Years and older (Adult, Older Adult) | NCT01591655 | 793 | July 2012 | September 2013 | October 2013 | May 4, 2012 | December 17, 2013 |
|
|||
44 | NCT02329743 | Completed Has Results |
Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
256 | All | 18 Years and older (Adult, Older Adult) | NCT02329743 | ATR-45-1401 | December 2014 | September 2015 | September 2015 | January 1, 2015 | February 5, 2019 | February 5, 2019 |
|
||
45 | NCT02491918 | Completed | Clinical Trial : Complications of in the Bag IOL Versus Optic Capture of IOL in Pediatric Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
61 | All | up to 4 Years (Child) | NCT02491918 | 13-009 2013 Research Foundation Grant |
April 2013 | April 2015 | April 2015 | July 8, 2015 | July 8, 2015 | ||||
46 | NCT01318499 | Completed Has Results |
Nepafenac 0.3% Two Study |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
1342 | All | 18 Years and older (Adult, Older Adult) | NCT01318499 | C-11-003 | March 2011 | September 2011 | September 2011 | March 18, 2011 | December 17, 2012 | December 17, 2012 |
|
||
47 | NCT01181752 | Unknown † | Proficiency of Eye Drop Instillation in Postoperative Cataract Patients in Ghana |
|
Observational |
|
Other |
|
|
300 | All | 19 Years and older (Adult, Older Adult) | NCT01181752 | H10-01479 | February 2012 | December 2012 | June 2013 | August 13, 2010 | March 1, 2012 |
|
|||||
48 | NCT01853072 | Completed Has Results |
Nepafenac Once Daily for Macular Edema - Study 1 |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
881 | All | 18 Years and older (Adult, Older Adult) | NCT01853072 | C-12-067 | June 2013 | May 2015 | May 2015 | May 14, 2013 | August 3, 2016 | August 3, 2016 | |||
49 | NCT01872611 | Completed Has Results |
Nepafenac Once Daily for Macular Edema - Study 2 |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
819 | All | 18 Years and older (Adult, Older Adult) | NCT01872611 | C-12-071 2013-001874-12 |
June 2013 | May 2015 | May 2015 | June 7, 2013 | August 2, 2016 | August 2, 2016 | |||
50 | NCT01124045 | Completed Has Results |
Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
80 | All | up to 3 Years (Child) | NCT01124045 | C-10-004 | August 2010 | April 2012 | April 2012 | May 14, 2010 | June 19, 2013 | June 19, 2013 |
|
||
51 | NCT00405730 | Completed | Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
227 | All | 18 Years and older (Adult, Older Adult) | NCT00405730 | C-04-65 2005-002647-35 |
November 2005 | July 2006 | July 2006 | November 30, 2006 | November 18, 2016 |
|
|||
52 | NCT00333268 | Completed | Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
369 | All | 18 Years and older (Adult, Older Adult) | NCT00333268 | C-04-14 | September 2004 | July 2005 | July 2005 | June 2, 2006 | March 5, 2012 |
|
|||
53 | NCT03531671 | Not yet recruiting | Assessing the Optics of the Eye Pre- and Post-operatively in Cataract |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT03531671 | KEAP1003 | CAT | May 23, 2018 | November 30, 2019 | November 30, 2019 | May 22, 2018 | May 22, 2018 | |||
54 | NCT01199510 | Completed | Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT01199510 | SMA-09-05 | September 2010 | June 2011 | June 2011 | September 13, 2010 | November 18, 2016 | ||||
55 | NCT00840580 | Completed | Effect on Wound Healing of Vigamox Versus Cravit |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
79 | All | 19 Years and older (Adult, Older Adult) | NCT00840580 | SMA-08-22 | January 2009 | September 2009 | February 10, 2009 | July 23, 2012 |
|
||||
56 | NCT02608489 | Completed Has Results |
Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
86 | All | 20 Years to 90 Years (Adult, Older Adult) | NCT02608489 | SCHUH 2013-12-012 | January 2014 | January 2015 | January 2015 | November 18, 2015 | October 17, 2016 | October 17, 2016 | |||
57 | NCT03205202 | Enrolling by invitation | Cataract and AMD in a Trial of a Multivitamin and Cocoa Extract |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
21445 | All | 60 Years and older (Adult, Older Adult) | NCT03205202 | 2016P001612 | COSMOS-Eye | June 1, 2015 | March 2020 | October 2020 | July 2, 2017 | June 12, 2018 | |||
58 | NCT00825747 | Unknown † | Evaluation of Seelens AF, an Aspheric Intra-Ocular Lens |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
60 | All | 18 Years to 90 Years (Adult, Older Adult) | NCT00825747 | SeeLensAF 65 | January 2009 | January 2010 | January 2010 | January 21, 2009 | January 21, 2009 |
|
|||
59 | NCT01310127 | Completed Has Results |
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1% |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
23 | All | 18 Years and older (Adult, Older Adult) | NCT01310127 | MAC-02-11 | November 2010 | April 2011 | May 2011 | March 8, 2011 | January 8, 2018 | September 26, 2013 | |||
60 | NCT02270879 | Completed | Multi-formula Optimization of Second Eye Refinement According to Direction of the Prediction Error of the First Eye |
|
|
Observational |
|
Other |
|
|
156 | All | 18 Years and older (Adult, Older Adult) | NCT02270879 | CHBaixoVouga | June 2014 | July 2014 | July 2014 | October 21, 2014 | October 21, 2014 | |||||
61 | NCT00774228 | Completed | I-ZIP Ocular Bandage Pivotal Study |
|
|
Interventional |
Not Applicable |
|
Industry | All | 18 Years and older (Adult, Older Adult) | NCT00774228 | ITX-08-002 | November 2008 | October 17, 2008 | August 10, 2009 |
|
||||||||
62 | NCT01161771 | Completed Has Results |
Effects of Cataract Extraction Surgery and Limbal Relaxing Incision on Corneal Sensation and Dry Eye |
|
|
Observational |
|
Industry |
|
|
32 | All | 50 Years and older (Adult, Older Adult) | NCT01161771 | MA-RES-09-004 | May 2010 | December 2010 | December 2010 | July 14, 2010 | July 26, 2012 | July 26, 2012 |
|
|||
63 | NCT03396003 | Completed | A Comparison of Two Devices for Taking Measurements of the Eye to Assist in Lens Selection for Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
112 | All | 18 Years and older (Adult, Older Adult) | NCT03396003 | ZIEMER_G6 | January 5, 2018 | August 1, 2018 | August 1, 2018 | January 10, 2018 | September 26, 2018 |
|
|||
64 | NCT02590744 | Recruiting | Effects of Preoperative Using of Eye Patches on Prevention of Emergence Agitation After Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
180 | All | 3 Years to 7 Years (Child) | NCT02590744 | Xiaoliang-Gan-2015 | October 2015 | October 2017 | October 2017 | October 29, 2015 | June 15, 2017 |
|
|||
65 | NCT01818037 | Completed | Long-term Postoperative Outcomes After Bilateral Congenital Cataract Surgery in Eyes With Microphthalmos |
|
|
Observational |
|
Other |
|
|
36 | All | 1 Month to 24 Months (Child) | NCT01818037 | 13-002 | January 2003 | March 2013 | March 2013 | March 26, 2013 | March 26, 2013 |
|
||||
66 | NCT02304900 | Completed | Effect of the Color of the Intra-eye Implant in the Cataract Surgery on the Sleep |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
400 | All | 60 Years to 90 Years (Adult, Older Adult) | NCT02304900 | PHRI09-PJP / IOL et sommeil | IOL et sommeil | December 2009 | December 2011 | December 2012 | December 2, 2014 | February 27, 2017 |
|
||
67 | NCT02137161 | Completed | Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
62 | All | 60 Years and older (Adult, Older Adult) | NCT02137161 | 2013-002066-39 | REPEX | November 2013 | October 2014 | October 2014 | May 13, 2014 | October 29, 2014 |
|
||
68 | NCT00352807 | Completed | Absorption of Brimonidine Ophthalmic Solution in the Aqueous Humor of Cataract Patients |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
22 | All | 18 Years and older (Adult, Older Adult) | NCT00352807 | 0501-45 | February 2005 | December 2005 | July 17, 2006 | October 17, 2007 |
|
||||
69 | NCT02150460 | Completed Has Results |
A Comparison of One-site and Two-site Peribulbar Anaesthesia for Cataract Surgery at Kaduna, Nigeria |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
100 | All | 50 Years and older (Adult, Older Adult) | NCT02150460 | NECKAD/TRIALS/001/2012 | October 2012 | December 2012 | June 2013 | May 29, 2014 | March 17, 2015 | March 17, 2015 |
|
||
70 | NCT01996839 | Completed | Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
514 | All | 18 Years and older (Adult, Older Adult) | NCT01996839 | 842 | December 2013 | May 2014 | July 2014 | November 27, 2013 | December 11, 2018 |
|
|||
71 | NCT00904904 | Completed | Indomethacin Eyedrops Compared With Ketorolac Eyedrops for Ocular Inflammation Following Cataract Surgery |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
120 | All | 18 Years and older (Adult, Older Adult) | NCT00904904 | 539 2007-004686-18 |
April 2008 | June 2009 | September 2009 | May 20, 2009 | August 13, 2012 |
|
|||
72 | NCT00698724 | Completed | Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT00698724 | 5359 | June 2008 | June 2009 | June 2009 | June 17, 2008 | June 10, 2009 |
|
|||
73 | NCT03766230 | Not yet recruiting | Clinical Study on Second-eye Pain in Cataract Surgery |
|
Observational |
|
Other |
|
|
600 | All | 40 Years to 80 Years (Adult, Older Adult) | NCT03766230 | YFZX2018006 | December 30, 2018 | August 30, 2021 | October 30, 2021 | December 6, 2018 | December 6, 2018 | ||||||
74 | NCT02351271 | Unknown † | Cataract Surgery: Femto LDV Z8 Versus Conventional |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
130 | All | 50 Years and older (Adult, Older Adult) | NCT02351271 | FL5940-0996 | COMFORT | February 2015 | November 2016 | December 2016 | January 30, 2015 | August 9, 2016 | |||
75 | NCT01109173 | Completed Has Results |
Confirmatory Study Nepafenac 0.3% |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
2120 | All | 18 Years and older (Adult, Older Adult) | NCT01109173 | C-09-055 | June 2010 | May 2011 | April 23, 2010 | November 30, 2012 | November 30, 2012 |
|
|||
76 | NCT00853970 | Completed Has Results |
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
299 | All | 18 Years and older (Adult, Older Adult) | NCT00853970 | CL-S&E-1205081-P | February 2009 | September 2009 | December 2009 | March 2, 2009 | January 25, 2013 | January 26, 2011 |
|
||
77 | NCT01666210 | Completed Has Results |
Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
60 | All | 21 Years and older (Adult, Older Adult) | NCT01666210 | OTX-12-002 | October 2012 | August 2013 | August 2013 | August 16, 2012 | April 27, 2017 | April 27, 2017 |
|
||
78 | NCT00333060 | Terminated | Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
164 | All | 50 Years and older (Adult, Older Adult) | NCT00333060 | OT-551-002 | November 2005 | January 2008 | June 2, 2006 | April 2, 2008 |
|
||||
79 | NCT02208297 | Completed | Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
322 | All | 18 Years and older (Adult, Older Adult) | NCT02208297 | 843 | September 2014 | March 2015 | March 2015 | August 5, 2014 | December 11, 2018 |
|
|||
80 | NCT01808560 | Completed Has Results |
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
34 | All | 55 Years to 85 Years (Adult, Older Adult) | NCT01808560 | LF005 | March 2013 | January 2015 | January 2015 | March 11, 2013 | September 3, 2018 | May 14, 2018 |
|
||
81 | NCT01898728 | Completed | Comparison of the Effectiveness of Povidone-iodine in Reducing Conjunctival Bacterial Load Prior to Cataract Surgery in Patients Treated With a Lidocaine Gel Dilating Formulation Versus Eye Drops: A Randomized Controlled Trial |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
101 | All | 18 Years and older (Adult, Older Adult) | NCT01898728 | Lidocaine gel vs drops | December 2012 | August 2013 | August 2013 | July 12, 2013 | March 22, 2018 |
|
|||
82 | NCT00333255 | Completed | Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
267 | All | 10 Years and older (Child, Adult, Older Adult) | NCT00333255 | C-04-41 | September 2005 | March 2006 | June 2, 2006 | July 8, 2009 |
|
||||
83 | NCT03740659 | Recruiting | Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
120 | All | 40 Years and older (Adult, Older Adult) | NCT03740659 | LevoDesa_05-2017 | iPERME | September 4, 2018 | March 2019 | March 2019 | November 14, 2018 | November 14, 2018 |
|
||
84 | NCT02761850 | Completed | Developmental Profile of Ocular Refraction in Patients With Congenital Cataract |
|
Observational |
|
Other |
|
|
1164 | All | Child, Adult, Older Adult | NCT02761850 | CCPMOH2016-China-2 | January 2010 | January 2016 | January 2016 | May 4, 2016 | May 5, 2016 |
|
|||||
85 | NCT02786901 | Completed | LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
600 | All | 18 Years and older (Adult, Older Adult) | NCT02786901 | 875 | June 2016 | June 13, 2017 | July 1, 2017 | June 1, 2016 | April 11, 2018 |
|
|||
86 | NCT00170729 | Completed | A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
62 | All | 40 Years and older (Adult, Older Adult) | NCT00170729 | ULT 491 A DE 01 | August 17, 2004 | February 28, 2005 | February 28, 2005 | September 15, 2005 | March 1, 2017 | ||||
87 | NCT02363530 | Unknown † | Corneal Protect Used During Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
100 | All | 40 Years to 85 Years (Adult, Older Adult) | NCT02363530 | Corneal Protect | CPUDCS | November 2014 | December 2015 | December 2015 | February 16, 2015 | November 20, 2015 |
|
||
88 | NCT02736175 | Completed Has Results |
OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
438 | All | 18 Years and older (Adult, Older Adult) | NCT02736175 | OTX-15-003 | October 2015 | May 2016 | July 2016 | April 13, 2016 | November 13, 2017 | October 11, 2017 | |||
89 | NCT00863759 | Completed | Wavefront Analysis and Contrast Sensitivity After Cataract Surgery With Akreos Advanced Optics Intraocular Lens Implantation |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
25 | All | 18 Years and older (Adult, Older Adult) | NCT00863759 | 656/06 | March 2009 | November 2009 | November 2009 | March 18, 2009 | July 2, 2010 |
|
|||
90 | NCT01455233 | Completed | 2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
60 | All | 18 Years and older (Adult, Older Adult) | NCT01455233 | STB-01 | STB-01 | September 2010 | February 2011 | February 2011 | October 19, 2011 | October 19, 2011 |
|
||
91 | NCT03278587 | Recruiting | Village-Integrated Eye Worker Trial II - Pilot |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
15000 | All | 50 Years and older (Adult, Older Adult) | NCT03278587 | 17-22776 | VIEW II Pilot | May 31, 2018 | May 2019 | December 2019 | September 11, 2017 | January 16, 2019 |
|
||
92 | NCT01298973 | Completed | Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
50 | All | 21 Years and older (Adult, Older Adult) | NCT01298973 | Alcon2011-VIS-001 | January 2011 | January 2012 | January 2012 | February 18, 2011 | January 18, 2012 |
|
|||
93 | NCT01882413 | Completed Has Results |
A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal |
|
|
Observational |
|
Industry |
|
|
204 | All | 50 Years and older (Adult, Older Adult) | NCT01882413 | GMA-RES-012-001 | REVEAL | June 2013 | March 2014 | March 2014 | June 20, 2013 | December 3, 2015 | December 3, 2015 |
|
||
94 | NCT03496467 | Completed | Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
63 | All | 22 Years to 99 Years (Adult, Older Adult) | NCT03496467 | NPIF-2018-01 | March 5, 2018 | December 17, 2018 | December 17, 2018 | April 12, 2018 | January 15, 2019 |
|
|||
95 | NCT03596723 | Terminated | KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
2 | All | up to 3 Years (Child) | NCT03596723 | KPI-121-C-010 | July 3, 2018 | September 28, 2018 | October 18, 2018 | July 24, 2018 | January 10, 2019 |
|
|||
96 | NCT02658071 | Recruiting | Measurement of Ocular Tensional Fluctuation by Triggerfish Lens Before and After Cataract Surgery in Patients With Exfoliative Glaucoma |
|
Observational |
|
Other / Industry |
|
|
10 | All | 18 Years and older (Adult, Older Adult) | NCT02658071 | TRIGGERFISH (RB 15.063) | TRIGGERFISH | March 15, 2016 | September 15, 2018 | September 15, 2018 | January 18, 2016 | June 14, 2017 |
|
||||
97 | NCT03778086 | Completed | Iridocorneal Angle and Anterior Segment Structure in Eyes of Children With Cataract |
|
|
Observational |
|
Other |
|
|
100 | All | 1 Year to 14 Years (Child) | NCT03778086 | ACA_LZL_HZ | ACA | June 1, 2016 | June 1, 2018 | September 1, 2018 | December 18, 2018 | December 18, 2018 | ||||
98 | NCT00763360 | Completed Has Results |
To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery. |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
184 | All | 49 Years and older (Adult, Older Adult) | NCT00763360 | AUS-S-07-01 | May 2008 | September 2010 | September 30, 2008 | January 24, 2012 | January 24, 2012 |
|
|||
99 | NCT02766907 | Completed | Optimizing the Ocular Surface Prior to Cataract Surgery |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
20 | All | 50 Years and older (Adult, Older Adult) | NCT02766907 | P015-2 | March 2016 | January 2017 | April 2018 | May 10, 2016 | April 24, 2018 |
|
|||
100 | NCT03001466 | Completed | A Randomized Controlled Trial Comparing Urea Loaded Nanoparticles to Placebo: a New Concept for Cataract Management |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
50 | All | 45 Years to 70 Years (Adult, Older Adult) | NCT03001466 | NCCM | January 2014 | January 2016 | September 2016 | December 23, 2016 | December 23, 2016 |
† Study has passed its completion date and status has not been verified in more than two years.